179 related articles for article (PubMed ID: 20934535)
1. Connecting the dots: role of standardization and technology sharing in biological simulation.
Ghosh S; Matsuoka Y; Kitano H
Drug Discov Today; 2010 Dec; 15(23-24):1024-31. PubMed ID: 20934535
[TBL] [Abstract][Full Text] [Related]
2. Multiscale modeling in drug discovery and development: future opportunities and present challenges.
Vicini P
Clin Pharmacol Ther; 2010 Jul; 88(1):126-9. PubMed ID: 20520608
[TBL] [Abstract][Full Text] [Related]
3. New approaches to drug discovery and development: a mechanism-based approach to pharmaceutical research and its application to BNP7787, a novel chemoprotective agent.
Hausheer FH; Kochat H; Parker AR; Ding D; Yao S; Hamilton SE; Petluru PN; Leverett BD; Bain SH; Saxe JD
Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S3-15. PubMed ID: 12819940
[TBL] [Abstract][Full Text] [Related]
4. The impact of assay technology as applied to safety assessment in reducing compound attrition in drug discovery.
Thomas CE; Will Y
Expert Opin Drug Discov; 2012 Feb; 7(2):109-22. PubMed ID: 22468913
[TBL] [Abstract][Full Text] [Related]
5. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
6. The impact of pharmacophore modeling in drug design.
Guner OF
IDrugs; 2005 Jul; 8(7):567-72. PubMed ID: 15973565
[TBL] [Abstract][Full Text] [Related]
7. Predictive biosimulation and virtual patients in pharmaceutical R and D.
Bangs A
Stud Health Technol Inform; 2005; 111():37-42. PubMed ID: 15718695
[TBL] [Abstract][Full Text] [Related]
8. Fostering culture and optimizing organizational structure for implementing model-based drug development.
Zhang L; Allerheiligen SR; Lalonde RL; Stanski DR; Pfister M
J Clin Pharmacol; 2010 Sep; 50(9 Suppl):146S-150S. PubMed ID: 20881228
[TBL] [Abstract][Full Text] [Related]
9. The role of pharmacokinetic and pharmacokinetic/pharmacodynamic modeling in drug discovery and development.
Yu XQ; Wilson AG
Future Med Chem; 2010 Jun; 2(6):923-8. PubMed ID: 21426110
[No Abstract] [Full Text] [Related]
10. Implementation of BacMam virus gene delivery technology in a drug discovery setting.
Kost TA; Condreay JP; Ames RS; Rees S; Romanos MA
Drug Discov Today; 2007 May; 12(9-10):396-403. PubMed ID: 17467576
[TBL] [Abstract][Full Text] [Related]
11. In silico prediction of ADME properties: are we making progress?
Beresford AP; Segall M; Tarbit MH
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):36-42. PubMed ID: 14982146
[TBL] [Abstract][Full Text] [Related]
12. Model-based drug development survey finds pharmacometrics impacting decision making in the pharmaceutical industry.
Stone JA; Banfield C; Pfister M; Tannenbaum S; Allerheiligen S; Wetherington JD; Krishna R; Grasela DM
J Clin Pharmacol; 2010 Sep; 50(9 Suppl):20S-30S. PubMed ID: 20881214
[TBL] [Abstract][Full Text] [Related]
13. The in silico child: using simulation to guide pediatric drug development and manage pediatric pharmacotherapy.
Läer S; Barrett JS; Meibohm B
J Clin Pharmacol; 2009 Aug; 49(8):889-904. PubMed ID: 19531673
[TBL] [Abstract][Full Text] [Related]
14. Model-based drug development: strengths, weaknesses, opportunities, and threats for broad application of pharmacometrics in drug development.
Wetherington JD; Pfister M; Banfield C; Stone JA; Krishna R; Allerheiligen S; Grasela DM
J Clin Pharmacol; 2010 Sep; 50(9 Suppl):31S-46S. PubMed ID: 20881215
[TBL] [Abstract][Full Text] [Related]
15. In silico prediction of clinical efficacy.
Michelson S; Sehgal A; Friedrich C
Curr Opin Biotechnol; 2006 Dec; 17(6):666-70. PubMed ID: 17046236
[TBL] [Abstract][Full Text] [Related]
16. Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization.
Peters SA; Ungell AL; Dolgos H
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):509-18. PubMed ID: 19562647
[TBL] [Abstract][Full Text] [Related]
17. Informatics and modeling challenges in fragment-based drug discovery.
Hubbard RE; Chen I; Davis B
Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
[TBL] [Abstract][Full Text] [Related]
18. Pharmacophore modeling and applications in drug discovery: challenges and recent advances.
Yang SY
Drug Discov Today; 2010 Jun; 15(11-12):444-50. PubMed ID: 20362693
[TBL] [Abstract][Full Text] [Related]
19. Biosimulation software is changing research.
Ho RL; Bartsell LT
Biotechnol Annu Rev; 2004; 10():297-302. PubMed ID: 15504712
[TBL] [Abstract][Full Text] [Related]
20. Statistical aspects in comparative benefit-risk assessment: challenges and opportunities for pharmaceutical statisticians.
Quartey G; Wang J
Pharm Stat; 2012; 11(1):82-5. PubMed ID: 21997832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
